Verona Pharma to Present Successful TQT Analysis Demonstrating No Clinically Relevant Effect on Cardiac Conduction at the American Thoracic Society 2022
Abstract supports ongoing Phase 3 program and planned NDA submission LONDON and RALEIGH, N.C., May…